Amount Raised
$130M
Round Type
Series B
Date Raised
Dec 1, 2025
Open roles (actively hiring)
Software EngineerProduct ManagerSales LeadMarketing+ 3 more
Get the founder's verified email + all open roles
Find my next client →About Protego Biopharma
Protego Biopharma: At the forefront of drug discovery targeting protein misfolding diseases operates in the biotechnology research sector and was founded in 2024. The company recently raised $130M in a Series B round (Dec 1, 2025), positioning the team to scale go-to-market, hire across functions, and evaluate new vendors over the coming quarter.
Why this raise matters
Protego Biopharma's $130M Series B raise signals serious investor confidence in their biotechnology research play. In the first 90 days post-funding, startups are 3x more likely to respond to outreach and evaluate new partnerships. Their team is hiring, their budget is unlocked, and they need solutions yesterday.
Frequently asked questions
- How much did Protego Biopharma raise?
- Protego Biopharma raised $130M in a Series B round on Dec 1, 2025.
- Who founded Protego Biopharma?
- Founder information for Protego Biopharma is available on JustRaised.
- Where is Protego Biopharma based?
- Location details for Protego Biopharma are available in the JustRaised database.
- How do I contact the founders of Protego Biopharma?
- Verified founder emails and LinkedIn profiles for Protego Biopharma are available on a JustRaised paid plan.